The Promise of iPS
Earlier this week, the Nobel Prize for Medicine was awarded to John B. Gurdon and Shinya Yamanaka for their pioneering work in cell reprogramming. The decision was not without controversy. Since Gurdon's early work was used as the basis for cloning projects (including Dolly the sheep), cell reprogramming, or pluripotent stem cells (iPS) technology, has been viewed with quite a bit of suspicion and fear.
Of course, much of that fear is rooted in a future that is far, far away from now. The science fiction version of cell reprogamming has us cloning ourselves (and maybe our pets), "designing" our babies and generally defying nature. And while many have talked about potential stem cell therapies, like replacing neurons in the substantia nigras of individuals with Parkinson's disease, we aren't there--and aren't likely to be there for a long, long time. There's still quite a bit of work to be done--and a lot of ethical considerations to be hashed out--before those kinds of programs are realized.
But, for me, the real promise of iPS, at this juncture, is to be able to better model neuropsychiatric disease--and test personalized treatments for those disorders.
Let me give you an example. When Shinya Yamanaka first transformed a skin cell into a stem cell back in 2006 by altering 4 genes, he inspired thousands of other researchers to embark on similar projects. One of his colleagues at the Gladstone Institute, Yadong Huang, took the idea and ran with it--managing to turn a skin cell into a neuron by simply changing one gene, Sox2. And with just one factor at play, Huang's group can reprogram cells with "zero tumor formation"--an issue that many other reprogramming techniques have.
Huang says that, ideally, one day, we might be able to replace cells obliterated by Alzheimer's disease. "Scientists like myself are very careful about talking about this. We know the brain is very different from other organs and there are many hurdles that must be overcome before we can begin to talk about using stem cell therapy in the brain," he said. And he's right.
But that doesn't mean iPS is not valuable now. Huang and other researchers are using these iPS cells to better understand the molecular mechanics of many neuropsychiatric disorders like Alzheimer's.
"Many of the cell culture studies done in Alzheimer's research do not involve human neurons," he told me. "It's hard to get human neurons. Sometimes you can get some after brain surgery. But it's just a small piece and you are taking that piece from someone with damage to the brain. This technique allows us to really study human neurons in culture and see if we can replicate many of the studies that are currently conducted in animal models."
Furthermore, these generated, living neural networks may help clinicians understand which treatments are best for individual patients. More and more, neuroscientists are learning that neuropsychiatric disorders are not single diseases but collections of various rare genetic disorders. One drug will not fit all. Huang can imagine a future where a patient donates a few skin cells in order to determine which drug is best for their version of the disease. "This is something that will help us make sure that we are giving patients safe, effective drugs in the future.”
Even without scientists running to inject stem cells into our brains, Gurdon and Yamanaka's win is an exciting coup for medicine. And I'm excited to see what the real, as opposed to the imagined, future of iPS will bring to the table.
Photo Credit: nobeastsofierce/Shutterstock.com
Step inside the unlikely friendship of a former ACLU president and an ultra-conservative Supreme Court Justice.
- Former president of the ACLU Nadine Strossen and Supreme Court Justice Antonin Scalia were unlikely friends. They debated each other at events all over the world, and because of that developed a deep and rewarding friendship – despite their immense differences.
- Scalia, a famous conservative, was invited to circles that were not his "home territory", such as the ACLU, to debate his views. Here, Strossen expresses her gratitude and respect for his commitment to the exchange of ideas.
- "It's really sad that people seem to think that if you disagree with somebody on some issues you can't be mutually respectful, you can't enjoy each other's company, you can't learn from each other and grow in yourself," says Strossen.
- The opinions expressed in this video do not necessarily reflect the views of the Charles Koch Foundation, which encourages the expression of diverse viewpoints within a culture of civil discourse and mutual respect.
Learn how to redesign your job for maximum reward.
- Broaching the question "What is my purpose?" is daunting – it's a grandiose idea, but research can make it a little more approachable if work is where you find your meaning. It turns out you can redesign your job to have maximum purpose.
- There are 3 ways people find meaning at work, what Aaron Hurst calls the three elevations of impact. About a third of the population finds meaning at an individual level, from seeing the direct impact of their work on other people. Another third of people find their purpose at an organizational level. And the last third of people find meaning at a social level.
- "What's interesting about these three elevations of impact is they enable us to find meaning in any job if we approach it the right way. And it shows how accessible purpose can be when we take responsibility for it in our work," says Hurst.
Erik Verlinde has been compared to Einstein for completely rethinking the nature of gravity.
- The Dutch physicist Erik Verlinde's hypothesis describes gravity as an "emergent" force not fundamental.
- The scientist thinks his ideas describe the universe better than existing models, without resorting to "dark matter".
- While some question his previous papers, Verlinde is reworking his ideas as a full-fledged theory.
TuSimple, an autonomous trucking company, has also engaged in test programs with the United States Postal Service and Amazon.
PAUL RATJE / Contributor
- This week, UPS announced that it's working with autonomous trucking startup TuSimple on a pilot project to deliver cargo in Arizona using self-driving trucks.
- UPS has also acquired a minority stake in TuSimple.
- TuSimple hopes its trucks will be fully autonomous — without a human driver — by late 2020, though regulatory questions remain.